Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2008-01-22
2008-01-22
Berch, Mark L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S282000
Reexamination Certificate
active
11218570
ABSTRACT:
The invention relates to substituted pyrido[1,2-a]pyrimidine compounds corresponding to formula (I)wherein:R1, R2and R3are as defined in the specification. Related pharmaceutical formulations and methods for inhibiting nitrogen oxide synthesis (NOS) and other treatments are also provided.
REFERENCES:
patent: 39 30 130 (1991-03-01), None
patent: 100 50 662 (2002-04-01), None
patent: WO 02/080911 (2002-10-01), None
Disorders Index of the National Institute of Neurological Disorders and Stroke, <http://www.ninds.nih.gov/disorders/disorder—index.htm?css=print>, downloaded Apr. 4, 2007.
Christopherson, et al., J. Clin. Invest., vol. 100, No. 10, Nov. 1997, 2424-2429.
Konopka, et al., Cancer Research 61, 3182-3187, Apr. 1, 2001.
Hjorth, et al., Eur. J. Clin. Pharmacol. 2003; 59:499-505 (2 page abstract attached).
Wolfe, et al., Ann. Pharmacother. Jan. 1995; 29(1): 36-46 (2 page abstract attached).
Akyurek, et al., Am. J. Path., vol. 149, 1981-1990, 1996 (5 page abstract).
Parenti, et al., FASEB. J. (Apr. 27, 2001) 10.1096/fj.00-0503fje.
NIH website, http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list—uids=7526964&dopt=Abstract, downloaded Jul. 19, 2007.
NIH Medline Plus website; http://www.nlm.nih.gov/medlineplus/ency/article/000170.htm#top, downloaded Jul. 19, 2007.
Girreser, et al., J. Prakt.Chem., 2000, 342, No. 3, pp. 230-234.
Mayo Clinic website, http://www.mayoclinic.com/print/migraine-headache/DS00120/DSECTION=8&METHOD=print, downloaded Jul. 19, 2007.
Medline Plus website, http://www.nlm.nih.gov/medlineplus/ency/article/000668.htm#top, downloaded Jul. 19, 2007.
Wikipedia printout, http://en.wikipedia.org/wiki/Inflammation, downloaded Jul. 17, 2007.
American Diabetes Assn. Website, http://www.diabetes.org/gestational-diabetes.jsp, downloaded Jul. 16, 2007.
Kids Health website; http://www.kidshealth.org/parent/infections/lung/meningitis.html, downloaded Jul. 19, 2007.
Ferid Murad, “Die Entdeckung Einiger Biologischer Wirkungen von Stickstoffmonoxid und Seiner Rolle für die Zellkommunikation (Nobel-Vortrag)”, Angew. Chem., 1999, pp. 1976-1989, vol. 111, Wiley-VCH.
Louis J. Ignarro, “Stickstoffmonoxid: ein Einzigartiges Endogenes Signalmolekül in der Gefäβbiologie (Nobel-Vortrag)”, Angew Chem., 1999, pp. 2002-2013, vol. 111, Wiley-VCH.
Harry L. Yale, ,,3-Benzoyl-2-Hydroxy-9-Methylpyrido [1,2-a] Pyrimdin-4-one, J. Heterocyclic Chem., (1978) pp. 1047-1049, vol. 15.
David Dubuisson, et al., “The Formalin Test: A Quantitative Study of the Analgesic Effects of Morphine, Meperidine, and Brain Stem Stimulation in Rats and Cats”, Pain, (1997), pp. 161-174, Elsevier/North-Holland Biomedical Press.
Oliver H. Lowry, et al., “Protein Measurement with the Folin Phenol Reagent”, May 28, 1951, pp. 265-275.
Terrence J. Coderre, et al. “Contribution of Central Neuroplasticity to Pathological Pain: Review of Clinical and Experimental Evidence”, Pain, (1993), pp. 259-285, vol. 52, Elsevier Science Publishers.
L. H. Lassen, et al., “Nitric Oxide Synthase Inhibition on Migraine”, Neuroreport, (Feb. 8, 1997), pp. 405, vol. 8.
Adrian J. Hobbs, “Inhibition of Nitric Oxide Synthase as a Potential Therapeutic Target”, Annu. Rev. Pharmacol. Toxicol., (1999), pp. 191-220, vol. 39, Copyright 1999 by Annual Review.
“Nitric Oxide: from Basic Research to Clinical Applications”, DDT, Feb. 1999, pp. 47-49, vol. 4, No. 2.
P.-E, et al., “Nitric Oxide Synthases: Target for Therapeutic Strategies in Neurological Diseases”, CMLS, Cell. Mo. Life Sci., (1999), pp. 1029-1035, vol. 55.
Ulrich Girreser, et al., “Synthesis and Reactions of Aroyl Substituted Enone Mannich Salts1”, J. Prakt. Chem., (2000), pp. 230-234, vol. 342, No. 3, Wiley-VCH.
Ulrich Girreser, et al., “An Efficient and Facile Synthesis of Novel 3-Benzoyl-3,4-Dihydro-2H-Pyrido [1,2-a] Pyrimidines”, Letters, (Mar. 1998), pp. 263-264.
Lars Lykke Thomsen, et al., “Nitric Oxide Theory of Migraine”, Clinical Neroscience, (1998), pp. 28-33, vol. 5, Wiley-Liss, Inc.
International Search report dated Jun. 6, 2004 (eight (8) pages).
German Search Report dated Nov. 25, 2003 (three sheets).
Bluhm Ullvi
Buschmann Helmut
Clement Bernd
Heber Dieter
Hennies Hagen-Heinrich
Berch Mark L.
Crowell & Moring LLP
Gruenenthal GmbH
Jaisle Cecilia M
LandOfFree
Substituted pyrido(1,2-a)pyrimidines and their use as NOS... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrido(1,2-a)pyrimidines and their use as NOS..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrido(1,2-a)pyrimidines and their use as NOS... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3939614